You’ve made it clear you’re not questioning COH’s credibility — and that’s exactly why this situation warrants more balance.
MD Anderson Cancer Center is leading the trial, and their involvement alone brings a level of clinical and ethical oversight that shouldn’t be dismissed lightly. They wouldn't risk their standing on flimsy data or allow their name to be associated with a company that’s misrepresenting trial outcomes.
As for CHM — yes, healthy skepticism is fine, but the update was more than a “one-liner.” It outlined that two out of three patients achieved CRi, a meaningful and measurable clinical outcome, and that no safety issues have been observed so far. This is exactly the kind of early signal you’d expect in a Phase 1B study designed to evaluate whether CORE-NK cells can enhance the effectiveness of standard-of-care treatments like Azacitidine and Venetoclax.
Suggesting alarm bells solely based on timing or forum chatter doesn’t acknowledge the complexity or credibility of a study being run by one of the top cancer centres in the world.
- Forums
- ASX - By Stock
- CHM
- Ann: ADVENT-AML Phase 1B clinical trial update
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.3¢

Ann: ADVENT-AML Phase 1B clinical trial update, page-94
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.747M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $1.858K | 619.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
66 | 58647032 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 107164382 | 32 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
66 | 58647032 | 0.003 |
30 | 25758480 | 0.002 |
19 | 63919001 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 107164382 | 32 |
0.005 | 44186931 | 30 |
0.006 | 20774758 | 20 |
0.007 | 3825018 | 5 |
0.008 | 7200898 | 3 |
Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |